|6 Months Ended|
Jun. 30, 2021
|Subsequent Events [Abstract]|
NOTE 15—SUBSEQUENT EVENTS
On August 12, 2021, the Board of Directors of the Company (the “Board”) elected Drs. Kathleen T. O’Loughlin, Carol Gomez Summerhays, and Martha Somerman to the Board. In addition, the Board appointed Jess Roper, a Director of the Company, to the Compensation Committee.
On August 12, 2021, Dr. Michael DiTolla and Garrett Sato resigned as members of the Board of Directors of the Company to pursue other interests.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://www.xbrl.org/2003/role/disclosureRef